An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells Redazione 23 Luglio 2020 ...
Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood? Redazione 23 Luglio 2020 ...
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory… Redazione 23 Luglio 2020 ...
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS Redazione 16 Luglio 2020 ...
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia Redazione 16 Luglio 2020 ...
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure Redazione 16 Luglio 2020 ...
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Redazione 16 Luglio 2020 ...
Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID‐19 critical patients Redazione 16 Luglio 2020 ...
Anti‐A isohaemagglutinin titres and SARS‐CoV‐2 neutralization: implications for children and taconvalescent plasma selection Redazione 16 Luglio 2020 ...
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA Redazione 9 Luglio 2020 ...
